Problem: Differences in circulating (peripheral) and mucosal T-cell phenotypes in chlamydia-infected women remain largely unknown.
| BACKGROUND
Chlamydia trachomatis (CT) infection is highly prevalent and associated with adverse reproductive outcomes. Our limited understanding of the T-cell phenotypes involved in CT infection comes primarily from murine models. In particular, the concomitant expression of CXCR3 + and CCR5 + on CD4 + T-cells has been shown in murine models to play a critical role in localizing protective effector T-cells to the genital mucosa, and loss of either receptor impairs protective immunity. 1 A single human study by
Ficarra et al. evaluated CD3
+ T-cell phenotypes in the peripheral blood and genital mucosa of women with uncomplicated CT infection, but did not differentiate CD3 + T-cells into CD4 + or CD8 + T-cells when evaluating homing and activation markers and they only evaluated a limited number of T-cell phenotypes. 2 No study in CT-infected humans has comprehensively investigated CD4 + and CD8 + T-cell phenotypes in the peripheral blood (the compartment where circulating lymphocytes reside) and genital mucosa (the site of active CT infection), which was the aim of our study.
| METHODS

| Ethics statement
This study was approved by the UAB IRB and the Jefferson County Department of Health. All subjects provided written consent prior to enrollment in the study.
| Study participants
Women presenting to a STD clinic in Birmingham, AL, USA, for treatment of a positive urogenital screening CT nucleic acid amplification test were enrolled in a CT immune response study, in which they had blood collected for peripheral blood mononuclear cells (PBMCS) and a cervicovaginal lavage (CVL) for mucosal mononuclear cells (MMCs) and were treated with azithromycin 1 g. Women co-infected with gonorrhea, syphilis, or HIV infection were excluded. In this study, we evaluated T-cell phenotypes in 13 CT-infected women who had suf- 
| Mononuclear cell isolation
| Flow cytometry
PBMCs and MMCs were stained with fluorescent antibodies against cell surface markers and analyzed using 10-color flow cytometry by previously reported methodology. show that at the genital tract mucosa in chlamydia-infected women, there is enhanced T-cell activation along with a higher expression of CCR5, a lower expression of CCR7, and association with a Th1 phenotype; in the peripheral blood, Th cells expressed predominantly a Th2-associated phenotype. *P < .05, **P < .001, *** P < .0001, or NS (not significant) by the Wilcoxon signed-rank test. Data are represented as median and interquartile range (IQR) side scatter profiles after exclusion of dead cells (Figure 1 ). Gates were either set using negative sample or Fluorescence Minus One (FMO) control and were then applied to all samples from each participant.
| Statistical analysis
Statistical analyses were performed using statistical analysis system (SAS) version 9.2 (SAS Institute, Cary, NC, USA). Comparisons of T-cell phenotypes between paired PBMCs and MMCs were done using the Wilcoxon signed-rank test.
| RESULTS AND DISCUSSION
We first investigated differences in the proportion of T-cell subsets We then evaluated expression of homing chemokine receptors (CKRs) at the peripheral blood vs mucosal site anticipating a lower proportion of these CKRs at the mucosa due to downregulation of these receptors upon arrival at the site of infection. We found lower expression of CCR7, an important T lymphocyte homing and memory marker, 4 in the genital mucosa for both CD4 + and CD8 + cells (both P = .0002) ( Figure 2C ). We found no significant difference in the expression of CXCR3, a marker of effector and memory cells that is also important in T-cell trafficking, on CD4 + cells between compartments;
however, CXCR3 expression on CD8 + cells trended toward being higher in the peripheral blood (P = .0771) ( Figure 2C ). We found expression of CCR5, an inflammatory homing marker that influences trafficking, to be higher in the genital mucosa for both CD4 + and CD8 + T-cells (P = .0266 and P = .0105). 2 Our finding of lower CCR7 expression and higher CCR5 expression in the genital mucosa for both CD4 Figure 2D ), which is in agreement with findings from a study by Miguel et al. 5 that showed that CT-infected women mounted a robust Th2 response. However, we found higher expression of Th1-associated CXCR3 + CCR5 + in the genital mucosa (CD4 + : P = .0046), suggesting CD4 + T-cells may polarize from Th2 to Th1 phenotypes once they arrive at the mucosa, the site of active infection. We observed a similar trend in expression of these markers in CD8 + T-cells (CCR4 + : P = .0002; CXCR3 + CCR5 + : P = .0171) ( Figure 2D ). The comparable expression of CCR4 and CXCR3 CCR5 for both CD4 + and CD8 + T-cells suggests that both of these T-cell subsets may be involved in response to CT infection. We also found a higher expression of CXCR3 + CCR4 + T-cells in the peripheral blood (CD4 + and CD8 + both P = .0002) ( Figure 2D) ; this T-cell phenotype has been previously reported to be expressed on regulatory T-cells in inflamed human liver tissue 6 and in synovial fluid of patients with juvenile idiopathic arthritis, 7 suggesting it may regulate Th cell polarization and/or could contribute to immunopathology in CT infection.
In summary, our investigation of differences in T-cell phenotypes between peripheral blood and the genital mucosa of CT-infected women revealed a greater proportion of activated T-cells at the genital mucosa, a lower expression of the homing and memory marker CCR7 and higher expression of homing marker CCR5 in the mucosa, and more frequent polarization toward a Th2-associated phenotype in the blood vs Th1-associated phenotype in the genital mucosa. Thus, T-cell phenotypes are distinct at the peripheral blood vs. genital mucosa sites in women with CT infection. This highlights the importance of studying both peripheral and mucosal compartments in CT infection, and our findings provide knowledge that will be important in future studies aimed at conducting a timecourse analysis of T-cell phenotypes from the time of CT infection to clearance and evaluating CT-specific function of these specific T-cell phenotypes.
